Annual revenue moved from KRW 15.9 billion in 2022 to KRW 15.6 billion in 2023 (down 1.7% year on year), then rose to KRW 16.1 billion in 2024 (up 3.0%) and KRW 19.2 billion in 2025 (up 19.4%). Revenue rose in 2024 and 2025, and 2025 was the largest year in the 2022–2025 period while 2023 was the smallest.
Operating profit was KRW 4.88 billion in 2022, KRW 5.03 billion in 2023 (up 3.1%), KRW 4.85 billion in 2024 (down 3.6%) and KRW 6.25 billion in 2025 (up 28.9%), with 2025 the largest and 2024 the smallest year. The operating margin stayed around 30%, at 30.8%, 32.3%, 30.2% and 32.6% from 2022 to 2025.
In 2025 the margin rose from 30.2% to 32.6% as revenue grew, so operating profit grew faster than revenue. Net income attributable to controlling shareholders was KRW 4.34 billion in 2022, KRW 5.59 billion in 2023 (up 28.8%), KRW 4.5 billion in 2024 (down 19.4%) and KRW 6.67 billion in 2025 (up 48.1%).
In 2023 that figure exceeded operating profit of KRW 5.03 billion, which suggests non-operating items contributed; the detail should be checked in the annual report notes. Net income including non-controlling interests equaled the controlling-shareholder figure in each year and was KRW 6.67 billion in 2025.
The company attributed the 2025 improvement to higher GFX revenue. Operating cash flow rose from KRW 5.57 billion in 2022 to KRW 7.28 billion in 2025.
On a quarterly basis, third-quarter 2025 revenue was KRW 5.07 billion with operating profit of KRW 1.7 billion; fourth-quarter 2025 revenue was KRW 5.1 billion (up 0.6% from the prior quarter) with operating profit of KRW 1.27 billion (down 24.8%).
First-quarter 2026 revenue fell to KRW 4 billion (down 21.7%) with operating profit of KRW 1.03 billion (down 19.5%). Second-quarter 2026 revenue recovered to KRW 5.36 billion (up 34.1%) and operating profit rose to KRW 2.1 billion (up 105.0%).
According to an Etoday report, the company put the second-quarter operating margin at 39.2% and credited strong skin-booster sales.
Third-quarter 2026 revenue was KRW 4.26 billion (down 20.6% from the prior quarter and down 16.0% year on year), operating profit was KRW 1.23 billion (down 41.6% and down 27.5%), and net income attributable to controlling shareholders was KRW 1.09 billion (down 44.8% and down 43.9%).
Over the latest four quarters (Q4 2025 to Q3 2026), net income attributable to controlling shareholders totaled KRW 5.56 billion. Whether the second-quarter jump reflected one-off items should be checked against quarterly detail.